neuroendocrine carcinoma

Showing 1 - 25 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Active, not recruiting
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Jul 21, 2022

Neuroendocrine Tumors - Patient Reported Outcomes

Enrolling by invitation
  • Neuroendocrine Tumors
  • +3 more
    • Gainesville, Florida
    • +13 more
    Jul 7, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

    Recruiting
    • Neuroendocrine Tumors
    • Neuroendocrine Carcinoma
    • Göttingen, Lower Saxony, Germany
    • +5 more
    Jun 27, 2022

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    Breast Cancer, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, Injection of hyperpolarized

    Enrolling by invitation
    • Breast Cancer
    • +3 more
    • Copenhagen, Denmark
      Rigshospitalet
    May 24, 2022

    Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Lu-DOTA-TATE
    • London, Ontario, Canada
      London Health Sciences Centre
    Apr 5, 2022

    Neuroendocrine Carcinoma Trial in France (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Aix-en-Provence, France
    • +6 more
    Mar 9, 2022

    Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston

    Recruiting
    • Lung Atypical Carcinoid Tumor
    • +13 more
    • Nivolumab
    • Stereotactic Body Radiation Therapy
    • Conroe, Texas
    • +2 more
    Feb 25, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Pancreas Tumor Trial in Roma, Rome (EUS guided radiofrequency ablation)

    Recruiting
    • Neuroendocrine Tumors
    • +3 more
    • EUS guided radiofrequency ablation
    • Roma, RM, Italy
    • +1 more
    Feb 10, 2022

    Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

    Active, not recruiting
    • Oncology
    • Neuroendocrine Carcinoma
    • Liposomal Irinotecan
    • +3 more
    • Glasgow, United Kingdom
    • +3 more
    Feb 3, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Beijing, Xiamen, Harbin (Chidamide, Etoposide + Cisplatin/Carboplatin)

    Recruiting
    • Neuroendocrine Tumors
    • Neuroendocrine Carcinoma
    • Beijing, Beijing, China
    • +2 more
    Nov 2, 2021

    Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • +2 more
    • VSV-IFNβ-NIS
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2021

    Lung Small Cell Carcinoma, Neuroendocrine Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Dostarlimab, Niraparib)

    Recruiting
    • Lung Small Cell Carcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2021

    Neuroendocrine Carcinoma, Digestive Cancer Trial in France (Neoadjuvant treatment, Adjuvant treatment)

    Recruiting
    • Neuroendocrine Carcinoma
    • Digestive Cancer
    • Neoadjuvant treatment
    • Adjuvant treatment
    • Amiens, France
    • +13 more
    Jun 10, 2021

    Neuroendocrine Carcinoma Trial in Los Angeles (68Ga-DOTATATE)

    Completed
    • Neuroendocrine Carcinoma
    • Los Angeles, California
      University of California Los Angeles, Nuclear Medicine Clinic of
    May 12, 2021

    Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)

    Recruiting
    • Neuroendocrine Carcinoma
    • FOLFOXIRI Protocol
    • Cisplatin injection
    • Caen, France
    • +5 more
    Apr 13, 2021

    Neuroendocrine Carcinoma Trial in Italy (CPT-11, Calcio levofolinate, 5-Fluorouracil)

    Recruiting
    • Neuroendocrine Carcinoma
    • Ancona, AN, Italy
    • +22 more
    Feb 25, 2021

    Neuroendocrine Carcinoma Trial in Beijing (Nab-paclitaxel Combined With Bevacizumab)

    Recruiting
    • Neuroendocrine Carcinoma
    • Nab-paclitaxel Combined With Bevacizumab
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 9, 2021

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +3 more
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Dec 13, 2020

    Early Treatment Response in NEN (REBORN)

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Somatostatin analog; chemotherapy
    • Rome, Italy
      Andrea M Isidori
    Dec 2, 2020

    Neuroendocrine Carcinoma Trial in Houston (68Ga-DOTATATE PET scan)

    Completed
    • Neuroendocrine Carcinoma
    • 68Ga-DOTATATE PET scan
    • Houston, Texas
      Radio- Isotope Therapy of America
    Oct 5, 2020

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

    Terminated
    • Neuroendocrine Tumors
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2020